IFNG and neoplasm: HLA silencing is a common tumor mechanism to evade cellular immunity, with tumors containing IFNγ or “inflamed” tumors conferring an improved prognosis and higher overall susceptibility to immunotherapy approaches such as immune checkpoint inhibitors (43).